Valion Bio Completes Oral Mucosal Formulation of Entolimod
Valion Bio announced completion of formulation work for an oral mucosal Entolimod using Shear Kershman’s BioViscid™, advancing a needle-free delivery pathway.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.